Evidence map›Paper›PMID 30598581›Full record

ArticleWorld journal of gastroenterology2018

Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine.

Fedor Amic, Domagoj Drmic, Zdenko Bilic, Ivan Krezic, Helena Zizek, Marina Peklic, Robert Klicek, Alen Pajtak, Enio Amic, Tinka Vidovic and 9 more

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Fedor AmicDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Domagoj DrmicDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Zdenko BilicDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Ivan KrezicDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Helena ZizekDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Marina PeklicDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Robert KlicekDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Alen PajtakDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Enio AmicDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Tinka VidovicDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Mislav RakicDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Marija Milkovic PerisaDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Katarina Horvat PavlovDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Antonio KokotDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Ante TvrdeicDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Alenka Boban BlagaicDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Mario ZovakDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Sven SeiwerthDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
Predrag SikiricDepartment of Pharmacology, Medical Faculty, University of Zagreb, Zagreb 10000, Croatia.
University of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate whether duodenal lesions induced by major venous occlusions can be attenuated by BPC 157 regardless nitric oxide (NO) system involvement.

methodsMale Wistar rats underwent superior anterior pancreaticoduodenal vein (SAPDV)-ligation and were treated with a bath at the ligated SAPDV site (BPC 157 10 μg, 10 ng/kg per 1 mL bath/rat; L-NAME 5 mg/kg per 1 mL bath/rat; L-arginine 100 mg/kg per 1 mL bath/rat, alone and/or together; or BPC 157 10 μg/kg instilled into the rat stomach, at 1 min ligation-time). We recorded the vessel presentation (filled/appearance or emptied/disappearance) between the 5 arcade vessels arising from the SAPDV on the ventral duodenum side, the inferior anterior pancreaticoduodenal vein (IAPDV) and superior mesenteric vein (SMV) as bypassing vascular pathway to document the duodenal lesions presentation; increased NO- and oxidative stress [malondialdehyde (MDA)]-levels in duodenum.

resultsUnlike the severe course in the SAPDV-ligated controls, after BPC 157 application, the rats exhibited strong attenuation of the mucosal lesions and serosal congestion, improved vessel presentation, increased interconnections, increased branching by more than 60% from the initial value, the IAPDV and SMV were not congested. Interestingly, after 5 min and 30 min of L-NAME and L-arginine treatment alone, decreased mucosal and serosal duodenal lesions were observed; their effect was worsened at 24 h, and no effect on the collateral vessels and branching was seen. Together, L-NAME+L-arginine antagonized each other's response, and thus, there was an NO-related effect. With BPC 157, all SAPDV-ligated rats receiving L-NAME and/or L-arginine appeared similar to the rats treated with BPC 157 alone. Also, BPC 157 in SAPDV-ligated rats normalized levels of NO and MDA, two oxidative stress markers, in duodenal tissues.

conclusionBPC 157, rapidly bypassing occlusion, rescued the original duodenal flow through IAPDV to SMV flow, an effect related to the NO system and reduction of free radical formation.

Indexed as

AnimalsArginineColitis, IschemicCollateral CirculationDisease Models, AnimalDuodenumHumansMaleNG-Nitroarginine Methyl EsterNitric OxideOxidative StressPeptide FragmentsProtective AgentsProteinsRandom AllocationRatsArginineBPC 157NG-Nitroarginine Methyl EsterNitric OxidePeptide FragmentsProtective AgentsProteinsBPC 157BypassingDuodenal lesionsL-arginineL-NAMEMajor venous occlusionRatsReduction of free radical formation

Identifiers

PMID30598581
PMCPMC6305534
OpenAlexW2905765253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.